by
Lauren Dubinsky, Senior Reporter | June 11, 2018
As with other areas of medicine, there is a precedent for organizing to implement political change. For example, neuroendocrine tumor advocacy groups such as the North American Neuroendocrine Tumor Society, Carcinoid Cancer Foundation and Carcinoid Cancer Awareness Network were instrumental in getting regulatory approval for one of the new drugs for neuroendocrine cancers that uses a PET radiopharmaceutical.
“Whether it changes farther in the future will depend on how people get appropriate organizations [involved,]” said Ghesani. “SNMMI is a small body and we have been making this plea for quite a while, and it hasn’t changed. If we get our forces going with patient support groups and also [manufacturers], it may change.”
Back to HCB News
Ad Statistics
Times Displayed: 2147
Times Visited: 10 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
